INS and Hepatic steatosis: In mice under a high-fat diet, 12-week intraperitoneal administration of urolithin A (20 μg/day) significantly improved systemic insulin sensitivity, attenuated liver steatosis, and reduced adipocyte hypertrophy and macrophage infiltration into the adipose tissue [32].